A Prospective Randomized Controlled Clinical Trial to evaluate the Efficacy and Safety of Ayurveda Interventions (Ashwagandha Tablet and Shunti Capsule) in the management of COVID-19 infection (Mild to Moderate symptoms)

Central Council for Research in Ayurvedic Sciences New Delhi0 个研究点目标入组 48 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Mild to moderate cases registered in the Hospital, with COVID 2019 (Confirmed by Antigen test/ RT-PCR) quarantined at identified hospital set up.
•2. Participants who can take medicines orally
•3. Patients with either sex, 18 to 75 years age
•4. Patients willing to provide signed informed consent

•1. Cases of severe vomiting which would make oral administration of medicine difficult.
•2. Patients with hyperacidity and gastric ulcer to be excluded.
•3. Chronic, Severe, Unstable, Uncontrolled co-existent medical illness such as Diabetes, Hypertension, Cardiac disorders, kidney disorders and lung disorders or other disease of concern which may put the patient at increased risk during the study
•4. Cases of respiratory failure and requiring mechanical ventilation.
•5. Patients with COVID 19 in critical condition or ARDS or NIAD 8 â??point ordinal score 2 Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
•6. Pregnant or lactating women
•7. Any patient with proved sensitivity to the trial drugs may be excluded.
•8. Any other condition, which as per the investigator would jeopardize the outcome of the trial.

发起方

Central Council for Research in Ayurvedic Sciences New Delhi